Skip to main content

Postoperative Infection

1
Pipeline Programs
2
Companies
3
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
1
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Spine BioPharma
Spine BioPharmaNY - New York
1 program
1
AntibioticPhase 41 trial
Active Trials
NCT01458223Completed645Est. Aug 2018
UNION therapeutics
UNION therapeuticsDenmark - Hellerup
2 programs
Preventive use of advanced antibioticsN/A1 trial
Study for Rapid Diagnosis of Postoperative Abdominal InfectionN/A1 trial
Active Trials
NCT05052619Recruiting297Est. Jul 2026
NCT05187871Unknown30Est. Dec 2022

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Spine BioPharmaAntibiotic
UNION therapeuticsStudy for Rapid Diagnosis of Postoperative Abdominal Infection
UNION therapeuticsPreventive use of advanced antibiotics

Clinical Trials (3)

Total enrollment: 972 patients across 3 trials

The Effect of Prolonged Postoperative Antibiotics Administration on Rate of Infection in Patients Undergoing Posterior Spine Surgery Requiring a Hemovac Drain

Start: Oct 2011Est. completion: Aug 2018645 patients
Phase 4Completed
NCT05187871UNION therapeuticsStudy for Rapid Diagnosis of Postoperative Abdominal Infection

Study for Rapid Diagnosis of Postoperative Abdominal Infection

Start: Aug 2021Est. completion: Dec 202230 patients
N/AUnknown
NCT05052619UNION therapeuticsPreventive use of advanced antibiotics

Preventive Therapy of Postoperative Intra-abdominal Infection Based on Serum Lactate Changes

Start: Jul 2021Est. completion: Jul 2026297 patients
N/ARecruiting

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 actively recruiting trials targeting 972 patients
2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.